loading
Sign up for newsletter

Vission.png

The Coalition for Life-Course Immunisation (CLCI) is a diverse network of expert individuals and associations representing public health, patients, academics and health professionals from across Europe.

We are committed to preventing infectious disease over the life-course by highlighting the benefits of wide-scale immunisation to our peers and to policy-makers.

Vaccines are not just for children – CLCI believes that vaccines are an important part of daily life at all ages and stages.

Member.png

The members of CLCI call on all stakeholders to ensure that they, their families and colleagues are immunised with all vaccines recommended for their stage of life – from infants to grandparents, from captains of industry to the shop floor, healthcare professionals, pregnant mothers, travellers, those suffering from chronic conditions – all are vulnerable because disease-causing bacteria and viruses know no boundaries.

Healthcare professionals remain the most trusted source of information on vaccines. By proactively advocating for immunisation, healthcare professionals can help to restore public confidence in immunisation.  

We hope the resources and information on this site will empower you to engage with the public and policy-makers to ensure optimal vaccine coverage.


A life-course approach to vaccination: adapting European Policies

Picture1.png

The Health Policy Partnership (HPP) developed a report looking at what adopting a life-course approach to vaccination means in practice – and highlighting key steps to achieve this. The report and accompanying infographics were launched in May 2018, with the endorsement of many leading experts in vaccination including members of the Coalition for Life-course Immunisation.

An open letter to the European Commission Directorate General for Health and Food Safety (DG SANTE) accompanied the launch of the report. In the open letter, the report’s authors express support for the European Commission’s proposal for a Council recommendation on strengthening European cooperation against vaccine-preventable diseases and call for all stakeholders to come together to ensure vaccination achieves its potential for future generations.

In October 2018, HPP organised a session at the European Health Forum Gastein entitled ‘Vaccines for all – leaving no one behind’, on behalf of MSD and the Coalition for Life-course Immunisation. The session included the launch of an animation created by HPP, explaining the benefits of a life-course approach to vaccination.


 

  • Our Blog

    Immunisation is for life

    The first CLCI blog has been prepared by Gary Finnegan, Editor of Vaccines Today

    Vaccines help to keep us healthy throughout our lives – life-course immunisation is graining momentum in public health policy

    What comes to mind when you think of vaccination? If the answer is infant immunisation against measles, polio or pertussis, you are only partially right. The days when vaccines were just for kids is long gone. Today, immunisations are recommended throughout life, protecting us against infectious diseases. 

    Take adolescence, for example. The HPV vaccine, typically given to young people aged 12 and 13 years, provides substantial protection against cervical cancer, genital warts and several other diseases caused by human papilloma viruses.

    In some countries, catch-up campaigns are reaching out to adolescents and young adults who missed out on their two MMR vaccines. Meningitis vaccination is offered to teenagers in several countries and regions, helping reduce their risk of death and serious illness from a deadly disease.

    Vaccines are also strongly recommended by experts – including the WHO, national health authorities and medical professionals – during pregnancy. Flu and whooping cough/pertussis vaccines, for example, are offered to women, helping to keep them and their babies healthy.

    Adults can avail of travel vaccines before jetting off to exotic locations on holiday or business. And, should you work in a healthcare setting, the chances are that you’ll be offered immunisations to protect you and vulnerable people from infectious diseases like influenza.

    Older people are another key target group for vaccination against flu, pneumococcal disease and shingles in several EU countries.

    This message is beginning to take hold among health experts and policymakers. Italy’s revamped ‘Calendar for Life’ is among the most comprehensive in the world. In revising its calendar to incorporate the latest scientific evidence, scientific societies worked with government officials to develop a fresh approach that offers protection to people of all ages.

    A comprehensive report published last year called on the EU to embrace vaccination for citizens of all ages. It highlighted the benefits to individuals, public health and the socioeconomic impact of embracing a life-course approach to vaccination.

    As national governments and European leaders focus on maintaining a healthy population – and collaborate through the Joint Action on Vaccination – now is the moment to come together to ensure that all citizens benefit from the protective power of vaccination.

    The CLCI will play an active role in raising awareness of life-course immunisation by engaging with decision-makers and the wider public to shift perceptions.

    Continue reading